- Trials with a EudraCT protocol (8,950)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
8,950 result(s) found.
Displaying page 27 of 448.
| EudraCT Number: 2014-001148-40 | Sponsor Protocol Number: ExcelsiorLOAD | Start Date*: 2014-06-02 | |||||||||||||||||||||
| Sponsor Name:Heart Center Freiburg - Bad Krozingen | |||||||||||||||||||||||
| Full Title: Pharmacodynamic comparison of thienopyridine loading strategies in patients undergoing elective coronary stenting | |||||||||||||||||||||||
| Medical condition: Stable patients with obstructive coronary heart disease undergoing elective percutaneous coronary stent implantation. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: DE (Ongoing) | |||||||||||||||||||||||
| Trial results: (No results available) | |||||||||||||||||||||||
| EudraCT Number: 2013-003244-23 | Sponsor Protocol Number: SICOG13/02 | Start Date*: 2014-03-19 | |||||||||||
| Sponsor Name:S.I.C.O.G. ONLUS | |||||||||||||
| Full Title: B-FOLFIRI followed by B-FOLFOX/B-XELOX or the reverse sequence versus standard B-FOLFIRI for the first-line treatment of metastatic colorectal cancer: a randomized SICOG study. SEveSTA study (Seq... | |||||||||||||
| Medical condition: Unresectable and metastatic colorectal cancer | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-001218-40 | Sponsor Protocol Number: SC12-02 | Start Date*: 2012-05-21 | |||||||||||
| Sponsor Name:FONDAZIONE SANTA LUCIA | |||||||||||||
| Full Title: EFFICACY OF ROTIGOTINE ON GAIT PERFORMANCE OF PARKINSONIAN PATIENTS | |||||||||||||
| Medical condition: Patients suffering for Idiopathic Parkinson’s Disease. H&Y stage > or = 2 with un-satisfactory control by on-going pharmacological therapy (Levodopa, COMT & MAO-inhibitors), characterised by an in... | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-001239-30 | Sponsor Protocol Number: CIR976101 | Start Date*: 2012-05-22 | |||||||||||
| Sponsor Name:Foundation for Liver Research | |||||||||||||
| Full Title: THE EFFECTS OF RECOMBINANT HUMAN INSULIN-LIKE GROWTH FACTOR-1 ON THE NUTRITIONAL STATUS IN PATIENTS WITH LIVER CIRRHOSIS: A PILOT-STUDY. | |||||||||||||
| Medical condition: Liver cirrhosis | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2012-002816-19 | Sponsor Protocol Number: Frax001 | Start Date*: 2012-10-25 |
| Sponsor Name:Rijnstate Hospital | ||
| Full Title: Prospective, pharmacokinetic study for determination of the relationship between lean body weight and anti-Xa activity 4 hours after subcutaneous injection of 5700 IU nadroparin in morbidly obese p... | ||
| Medical condition: patients; perioperative in bariatric surgery | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2012-004785-18 | Sponsor Protocol Number: PKBoxing-1 | Start Date*: 2014-11-18 |
| Sponsor Name:University Medical Center Groningen | ||
| Full Title: PET imaging of neuroinflammatory consequences of chronic repetitive head injury in Muay Thai boxing | ||
| Medical condition: n/a | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-002161-27 | Sponsor Protocol Number: DUETII01 | Start Date*: 2016-04-15 |
| Sponsor Name:Sint Antonius Hospital | ||
| Full Title: Dutch randomized trial comparing Ultrasound-accElerated Thrombolysis with standard dose Urokinase versus half dose Urokinase for thrombo-embolic infra-inguinal arterial disease (DUET II) | ||
| Medical condition: Acute thrombo-embolic occlusion of one of the infra-inguinal arteries | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-005700-28 | Sponsor Protocol Number: AIDA_104599 | Start Date*: 2016-04-20 | |||||||||||
| Sponsor Name:Erasmus MC | |||||||||||||
| Full Title: An evaluation of the effectivity of the current treatment of uncomplicated urinary tract infections with fosfomycin. | |||||||||||||
| Medical condition: Healthy volunteers | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-001959-24 | Sponsor Protocol Number: BoTN-Study | Start Date*: 2014-08-26 |
| Sponsor Name:University Hospital Essen | ||
| Full Title: BoTN: Onabotulinumtoxin A for the treatment of trigeminal neuralgia: Efficacy, safety and neurophysiological alterations under therapy – a prospective, controlled trial | ||
| Medical condition: Trigeminal neuralgia | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-002455-26 | Sponsor Protocol Number: IRON-CMR | Start Date*: 2014-09-20 |
| Sponsor Name:Karolinska Institute | ||
| Full Title: The use of intravenous Iron oxide as a contrast agent for cardiac magnetic resonance imaging. | ||
| Medical condition: Cardiovascular diseases: Acute myocardial infarction, chronic myocardial infarction, myocardial ischemia, myocarditis, diffuse myocardial fibrosis. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-001417-24 | Sponsor Protocol Number: PLEIADES | Start Date*: 2017-02-22 |
| Sponsor Name:Franciscus Gasthuis | ||
| Full Title: POSTPRANDIAL LIPEMIA, INFLAMMATION, AND VASCULAR FUNCTION IN DIABETES MODULATED BY SGLT2 INHIBITION | ||
| Medical condition: Diabetes Mellitus type II | ||
| Disease: | ||
| Population Age: Adults | Gender: Male | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-001541-24 | Sponsor Protocol Number: NeuroIPT-1 | Start Date*: 2016-03-07 |
| Sponsor Name:University Medical Center Freiburg | ||
| Full Title: Neuroenhancement of Interpersonal Psychotherapy in Major Depression | ||
| Medical condition: Major Depression (ICD-10; F32.2/F33.2) | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-004794-41 | Sponsor Protocol Number: Vista | Start Date*: 2017-03-02 |
| Sponsor Name:Academical medical centre, dep of internal medicine | ||
| Full Title: Arterial wall inflammation measured with 18F-FDG PET/CT in patients with statin intolerance before and after treatment with a PCSK-9 inhibitor | ||
| Medical condition: Patients with CV-risk and statin intolerance due to statin-associated muscle symptoms (SAMS) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-002478-37 | Sponsor Protocol Number: 61682 | Start Date*: 2018-01-11 |
| Sponsor Name:VU University Medical Center | ||
| Full Title: Right Dose, Right Now: Randomized Clinical Trial | ||
| Medical condition: Infectious disease, sepsis | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-004236-38 | Sponsor Protocol Number: 12250 | Start Date*: 2017-01-24 |
| Sponsor Name:University of Oxford | ||
| Full Title: OPtimising Treatment for MIld Systolic hypertension in the Elderly: a randomised controlled trial | ||
| Medical condition: Hypertension | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: GB (GB - no longer in EU/EEA) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-002636-16 | Sponsor Protocol Number: VUMC-ANW-MS-GG-062017 | Start Date*: 2017-10-09 |
| Sponsor Name:VU University medical center Amsterdam | ||
| Full Title: Cognitive impairment and functional reorganization in multiple sclerosis: The role of GABA and glutamate | ||
| Medical condition: Multiple Sclerosis (MS). And specifically cognitive problems in MS. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-001260-37 | Sponsor Protocol Number: PRODEO | Start Date*: 2017-05-23 | |||||||||||
| Sponsor Name:Zuyderland Medical Center | |||||||||||||
| Full Title: PRODEO: PROfylactic Haloperidol in patients defined as high risk for DElirium with delirium risk mOdel | |||||||||||||
| Medical condition: Delirium | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-004735-39 | Sponsor Protocol Number: M14NEC | Start Date*: 2015-11-10 |
| Sponsor Name:NKI-AVL | ||
| Full Title: Phase II Study of cisplatin and everolimus in patients with metastatic or unresectable neuroendocrine carcinomas (NEC) of extrapulmonary origin | ||
| Medical condition: Patients with metastatic neuroendocrine carcinomas of extrapulmonary origin will be eligible | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-004119-19 | Sponsor Protocol Number: 2015-005-M | Start Date*: 2016-04-25 |
| Sponsor Name:Reinier de Graaf Hospital | ||
| Full Title: Femoral Nerve Blockage in Proximal Femoral Fractures in patients of 65 years of age or older, a Randomised Controlled Trial | ||
| Medical condition: Pain in patients with a proximal femoral fracture. | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-000042-22 | Sponsor Protocol Number: PI16/00720 | Start Date*: 2017-05-11 |
| Sponsor Name:GAP MALLORCA | ||
| Full Title: Randomized, pragmátic, open-label clinical trial with blind evaluator, to evaluate the efficacy efficacy of continuing drug treatment in patients with advanced dementia. | ||
| Medical condition: Advanced dementia | ||
| Disease: | ||
| Population Age: Elderly | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.